Literature DB >> 8661152

Molecular cloning and chromosomal mapping of the mouse gene encoding cyclin-dependent kinase 5 regulatory subunit p35.

T Ohshima1, C A Kozak, J W Nagle, H C Pant, R O Brady, A B Kulkarni.   

Abstract

A neural-specific activating subunit, p35, of cyclin-dependent kinase 5 (Cdk5) was recently reported to differ from other mammalian cyclins, suggesting a new type of regulatory subunit for Cdk activity. The mouse gene encoding p35, Cdk5r, was isolated from a mouse 129/SvJ genomic library, and the genomic structure of Cdk5r was characterized. The most notable features of Cdk5r are the absence of introns in the amino acid coding region and the high homology of amino acid sequence among species. The 5'-flanking region of Cdk5r contained no canonical TATA or CAAT box but had several putative promoter elements, including Sp1, AP2, MRE, and NGFIA. The mouse Cdk5r transcript was detected only in the brain by Northern blot analysis. Mouse Cdk5r was mapped to a position on mouse chromosome 11.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661152     DOI: 10.1006/geno.1996.0370

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.

Authors:  Allison Leso; Syed W Bihaqi; Anwar Masoud; Joanna K Chang; Asma Lahouel; Nasser Zawia
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-26

2.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors:  Lina Adwan; Gehad M Subaiea; Riyaz Basha; Nasser H Zawia
Journal:  J Neurochem       Date:  2014-10-18       Impact factor: 5.372

3.  Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling.

Authors:  Satoru Takahashi; Toshio Ohshima; Andrew Cho; Taduru Sreenath; Michael J Iadarola; Harish C Pant; Yong Kim; Angus C Nairn; Roscoe O Brady; Paul Greengard; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

4.  Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.

Authors:  T Ohshima; M Ogawa; M Hirasawa; G Longenecker; K Ishiguro; H C Pant; R O Brady; A B Kulkarni; K Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous.

Authors:  T Ohshima; E C Gilmore; G Longenecker; D M Jacobowitz; R O Brady; K Herrup; A B Kulkarni
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

6.  Cyclin-dependent kinase 5 activity regulates pain signaling.

Authors:  Tej K Pareek; Jason Keller; Sashi Kesavapany; Harish C Pant; Michael J Iadarola; Roscoe O Brady; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

Review 7.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

8.  Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.

Authors:  Elias Utreras; Akira Futatsugi; Parvathi Rudrabhatla; Jason Keller; Michael J Iadarola; Harish C Pant; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

9.  Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Authors:  T Ohshima; J M Ward; C G Huh; G Longenecker; H C Pant; R O Brady; L J Martin; A B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.